JCN Newswire
TOKYO, Oct 8, 2024 – (JCN Newswire) – Eisai Co., Ltd. announced today that it has received approval for “URECE® Tablets” (dotinurad) in Thailand as a treatment for gout and hyperuricemia. This approval is the first time that the agent has been approved in China or the five ASEAN (Association of Southeast Asian Nations) member states where Eisai holds licenses to develop and distribute the agent.“URECE Tablets” are a new therapeutic medicine for gout and hyperuricemia discovered by FUJI YAKUHIN…
Read More
“Urece Tablets” (Dotinurad) Approved In Thailand For Gout And Hyperuricemia
Alejandro Mayoral
20:43
TOKYO, Oct 8, 2024 – (JCN Newswire) – Eisai Co., Ltd. announced today that it has received approval for “URECE® Tablets” (dotinurad) in Thailand as a treatment for gout and hyperuricemia. This approval is the first time that the agent has been approved in China or the five ASEAN (Association of Southeast Asian Nations) member
